People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nanomr, Inc. | — | Biotechnology | Series A | $18.5M | $86.8M | 2013 |
Steve C. Gullans at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steve C. Gullans on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gavin Christensen | 1 | 23 |
| Sally Corning | 1 | 5 |
| Waneta C. Tuttle | 1 | 4 |
| Victor Esch | 1 | 2 |
| Sally C. Corning | 1 | 1 |
| Lisa C, Dunlea | 1 | 1 |
| Victor C. Esch | 1 | 1 |
| Steven C. Gullans | 1 | 1 |
| Gavin C. Christensen | 1 | 1 |
| Augustine C. Lawlor | 1 | 1 |
| Caroline C. Popper | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.